PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT PART 03: RESEARCH METHODOLOGY PART 04: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 05: MARKET SIZING • Market definition • Market sizing 2017 • Market size and forecast 2017-2022 PART 06: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 07: MARKET SEGMENTATION BY PRODUCTS AND SERVICES • Segmentation by product and services • Comparison by product and services • Products – Market size and forecast 2017-2022 • Services – Market size and forecast 2017-2022 • Market opportunity by products and services PART 08: CUSTOMER LANDSCAPE PART 09: REGIONAL LANDSCAPE • Geographical segmentation • Regional comparison • Americas – Market size and forecast 2017-2022 • EMEA – Market size and forecast 2017-2022 • APAC – Market size and forecast 2017-2022 • Market opportunity PART 10: DECISION FRAMEWORK PART 11: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 12: MARKET TRENDS • Increasing importance of promotional activities • Increasing popularity of personalized medicine • Growth in life science and pharmaceutical industries PART 13: VENDOR LANDSCAPE • Overview • Landscape disruption PART 14: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • BD • Bio-Rad Laboratories • Merck KGaA • Promega • QIAGEN • Thermo Fisher Scientific PART 15: APPENDIX • List of abbreviations     Exhibit 01: Parent market Exhibit 02: Global proteomics market Exhibit 03: Market characteristics Exhibit 04: Market segments Exhibit 05: Market definition - Inclusions and exclusions checklist Exhibit 06: Market size 2017 Exhibit 07: Validation techniques employed for market sizing 2017 Exhibit 08: Global protein expression market – Market size and forecast 2017-2022 ($ mn) Exhibit 09: Global protein expression market – Year-over-year growth 2018-2022 (%) Exhibit 10: Five forces analysis 2017 Exhibit 11: Five forces analysis 2022 Exhibit 12: Bargaining power of buyers Exhibit 13: Bargaining power of suppliers Exhibit 14: Threat of new entrants Exhibit 15: Threat of substitutes Exhibit 16: Threat of rivalry Exhibit 17: Market condition - Five forces 2017 Exhibit 18: Product and services – Market share 2017-2022 (%) Exhibit 19: Comparison by product and services Exhibit 20: Products – Market size and forecast 2017-2022 ($ mn) Exhibit 21: Products – Year-over-year growth 2018-2022 (%) Exhibit 22: Services – Market size and forecast 2017-2022 ($ mn) Exhibit 23: Services – Year-over-year growth 2018-2022 (%) Exhibit 24: Market opportunity by products and services Exhibit 25: Customer landscape Exhibit 26: Global protein expression market – Market share by geography 2017-2022 (%) Exhibit 27: Regional comparison Exhibit 28: Americas – Market size and forecast 2017-2022 ($ mn) Exhibit 29: Americas – Year-over-year growth 2018-2022 (%) Exhibit 30: Top 3 countries in Americas Exhibit 31: EMEA – Market size and forecast 2017-2022 ($ mn) Exhibit 32: EMEA – Year-over-year growth 2018-2022 (%) Exhibit 33: Top 3 countries in EMEA Exhibit 34: APAC – Market size and forecast 2017-2022 ($ mn) Exhibit 35: APAC – Year-over-year growth 2018-2022 (%) Exhibit 36: Top 3 countries in APAC Exhibit 37: Market opportunity Exhibit 38: Vendor landscape Exhibit 39: Landscape disruption Exhibit 40: Vendors covered Exhibit 41: Vendor classification Exhibit 42: Market positioning of vendors Exhibit 43: BD overview Exhibit 44: BD – Business segments Exhibit 45: BD – Organizational developments Exhibit 46: BD – Geographic focus Exhibit 47: BD – Segment focus Exhibit 48: BD – Key offerings Exhibit 49: Bio-Rad Laboratories overview Exhibit 50: Bio-Rad Laboratories – Business segments Exhibit 51: Bio-Rad Laboratories – Organizational developments Exhibit 52: Bio-Rad Laboratories – Geographic focus Exhibit 53: Bio-Rad Laboratories – Segment focus Exhibit 54: Bio-Rad Laboratories – Key offerings Exhibit 55: Merck KGaA overview Exhibit 56: Merck KGaA – Business segments Exhibit 57: Merck KGaA – Organizational developments Exhibit 58: Merck KGaA – Geographic focus Exhibit 59: Merck KGaA – Segment focus Exhibit 60: Merck KGaA – Key offerings Exhibit 61: Promega overview Exhibit 62: Promega – Organizational developments Exhibit 63: Promega – Key offerings Exhibit 64: QIAGEN overview Exhibit 65: QIAGEN – Product segments Exhibit 66: QIAGEN – Organizational developments Exhibit 67: QIAGEN – Geographic focus Exhibit 68: QIAGEN – Segment focus Exhibit 69: QIAGEN – Key offerings Exhibit 70: Thermo Fisher Scientific overview Exhibit 71: Thermo Fisher Scientific – Business segments Exhibit 72: Thermo Fisher Scientific – Organizational developments Exhibit 73: Thermo Fisher Scientific – Geographic focus Exhibit 74: Thermo Fisher Scientific – Segment focus Exhibit 75: Thermo Fisher Scientific – Key offerings

BD Bio-Rad Laboratories Merck KGaA Promega QIAGEN Thermo Fisher Scientific